188 related articles for article (PubMed ID: 1673852)
1. Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine.
Sanfilippo O; Ronchi E; De Marco C; Di Fronzo G; Silvestrini R
Eur J Cancer; 1991; 27(2):155-8. PubMed ID: 1673852
[TBL] [Abstract][Full Text] [Related]
2. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation.
Hill BT; Whelan RD; Hurst HC; McClean S
Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070
[TBL] [Abstract][Full Text] [Related]
3. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
4. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining.
Salmon SE; Grogan TM; Miller T; Scheper R; Dalton WS
J Natl Cancer Inst; 1989 May; 81(9):696-701. PubMed ID: 2565403
[TBL] [Abstract][Full Text] [Related]
5. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine.
Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J
Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies.
Wishart GC; Plumb JA; Going JJ; McNicol AM; McArdle CS; Tsuruo T; Kaye SB
Br J Cancer; 1990 Nov; 62(5):758-61. PubMed ID: 1978783
[TBL] [Abstract][Full Text] [Related]
7. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers.
Veneroni S; Zaffaroni N; Daidone MG; Benini E; Villa R; Silvestrini R
Eur J Cancer; 1994; 30A(7):1002-7. PubMed ID: 7946563
[TBL] [Abstract][Full Text] [Related]
8. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.
Lee FY; Sciandra J; Siemann DW
Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574
[TBL] [Abstract][Full Text] [Related]
9. mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles.
Gekeler V; Weger S; Probst H
Biochem Biophys Res Commun; 1990 Jun; 169(2):796-802. PubMed ID: 1972623
[TBL] [Abstract][Full Text] [Related]
10. Correlations between natural resistance to doxorubicin, proliferative activity, and expression of P-glycoprotein 170 in human kidney tumor cell lines.
Efferth T; Löhrke H; Volm M
Urol Res; 1990; 18(5):309-12. PubMed ID: 1979457
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines.
Schott B; Londos-Gagliardi D; Ries C; Huet S; Robert J
J Cancer Res Clin Oncol; 1993; 119(9):527-32. PubMed ID: 8100823
[TBL] [Abstract][Full Text] [Related]
12. Dominant expression of multiple drug resistance after in vitro X-irradiation exposure in intraspecific Chinese hamster ovary hybrid cells.
McClean S; Hosking LK; Hill BT
J Natl Cancer Inst; 1993 Jan; 85(1):48-53. PubMed ID: 8093217
[TBL] [Abstract][Full Text] [Related]
13. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.
Dixon AR; Bell J; Ellis IO; Elston CW; Blamey RW
Br J Cancer; 1992 Sep; 66(3):537-41. PubMed ID: 1355661
[TBL] [Abstract][Full Text] [Related]
15. Comparison of western blot analysis and immunocytochemical detection of P-glycoprotein in multidrug resistant cells.
Friedlander ML; Bell DR; Leary J; Davey RA
J Clin Pathol; 1989 Jul; 42(7):719-22. PubMed ID: 2569484
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM.
Kimiya K; Naito S; Soejima T; Sakamoto N; Kotoh S; Kumazawa J; Tsuruo T
J Urol; 1992 Aug; 148(2 Pt 1):441-5. PubMed ID: 1353119
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer.
Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E
J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer.
Ro J; Sahin A; Ro JY; Fritsche H; Hortobagyi G; Blick M
Hum Pathol; 1990 Aug; 21(8):787-91. PubMed ID: 1974874
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
20. Prediction of doxorubicin resistance in gastrointestinal cancer by P-glycoprotein staining.
Yamauchi M; Kumazawa H; Satta T; Sugawara I; Isobe K; Kodera Y; Ito K; Watanabe T; Takagi H
Eur J Cancer; 1992; 28A(8-9):1422-7. PubMed ID: 1355349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
